T1	Participants 49 115	predominantly classic neovascular age-related macular degeneration
T2	Participants 308 400	Predominantly Classic Choroidal Neovascularization [CNV] in Age-Related Macular Degeneration
T3	Participants 490 502	423 patients
T4	Participants 772 789	A subset (n = 61)
